Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

uPAR exhibits age- and region-dependent expression in the brains of mice with Alzheimer's disease-like pathology.

Brain research·2026

Same author

Replicable generation of rhesus macaque iPSCs for <i>in vitro</i> modeling of genetic frontotemporal dementia.

bioRxiv : the preprint server for biology·2026

Same author

Comparative analysis of sex-dependent serum metabolomic patterns across the lifespan of rhesus macaques.

Frontiers in genetics·2025

Same author

Variable Neuronal Expression of Green Florescent Protein in the Brain of a Transgenic Swine Reporter Model.

Next research·2025

Same author

Tau and tauopathies across primate species: implications for modeling neurodegenerative disorders.

Frontiers in aging neuroscience·2025

Same author

Position paper: leveraging non-human primate (NHP) specificities to accelerate Parkinson's disease and ageing research.

NPJ Parkinson's disease·2025

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Can we prevent parkinson's disease?

Christine R Swanson¹, Samantha L Sesso, Marina E Emborg

¹Preclinical Parkinson's Research Program, Wisconsin National Primate Research Center;, University of Wisconsin-Madison, Madison, WI, USA.

Frontiers in Bioscience (Landmark Edition)

|March 11, 2009

Summary

This summary is machine-generated.

Parkinson's disease (PD) risk factors and protective elements are reviewed. Understanding these elements may help prevent or slow PD progression in affected individuals.

Related Experiment Videos

Last Updated: Jun 25, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Area of Science:

Neurodegenerative disorders
Epidemiology
Neuroprotection

Background:

Parkinson's disease (PD) is a progressive neurodegenerative disorder impacting 1 million Americans.
The exact cause of PD remains unknown.
Risk and neuroprotective factors for PD have been identified.

Purpose of the Study:

To review current findings on risk and neuroprotective factors in Parkinson's disease.
To discuss the influence of these factors on PD development and progression.

Main Methods:

Review of basic science research.
Analysis of clinical findings.
Examination of epidemiological data.

Main Results:

Identified factors that increase the risk of developing PD.
Identified factors that may prevent or slow PD progression.
Summarized current knowledge on PD risk and neuroprotection.

Conclusions:

Understanding risk and protective factors is crucial for managing Parkinson's disease.
Further research into these factors could lead to novel therapeutic strategies.
This review consolidates key findings for researchers and clinicians.